Cargando…

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels

We sought to investigate whether levels of matrix metalloproteinases (MMPs) and their inhibitors predict coronary atherosclerotic plaque instability, as assessed by intravascular ultrasound (IVUS) virtual histology during coronary angiography. Blood samples were collected before angiography in 32 su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ezhov, Marat, Safarova, Maya, Afanasieva, Olga, Mitroshkin, Maksim, Matchin, Yuri, Pokrovsky, Sergei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523150/ https://www.ncbi.nlm.nih.gov/pubmed/30934954 http://dx.doi.org/10.3390/biom9040129

Ejemplares similares

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2022)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
por: Afanasieva, Olga I., et al.
Publicado: (2021)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2023)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Role of chemokines in promoting instability of coronary atherosclerotic plaques and the underlying molecular mechanism
por: Zhong, Z.X., et al.
Publicado: (2014)

Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease
por: Niccoli, Giampaolo, et al.
Publicado: (2016)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Expression of osteopontin in calcified coronary atherosclerotic plaques.
por: Kwon, H. M., et al.
Publicado: (2000)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
por: McGarrah, Robert W., et al.
Publicado: (2022)

HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease
por: Andrassy, Martin, et al.
Publicado: (2012)

Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study
por: Otani, Tomoyuki, et al.
Publicado: (2022)

Evaluation of Atherosclerotic Plaque in Non-invasive Coronary Imaging
por: Dwivedi, Aeshita, et al.
Publicado: (2018)

Correction: HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease
Publicado: (2014)

Low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients
por: Guan, Xue-qiang, et al.
Publicado: (2018)

Association of Difference in Coronary Sinus Diameter by Computed Tomographic Angiography Between Patients in and Not in Stable Atherosclerotic Plaque(S)
por: Li, Yancui, et al.
Publicado: (2018)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

Prevalence of coronary atherosclerotic plaque in patients with a low coronary artery calcium score
por: Mehta, VS, et al.
Publicado: (2012)

A Proteomic Study of Atherosclerotic Plaques in Men with Coronary Atherosclerosis
por: Stakhneva, Ekaterina M., et al.
Publicado: (2019)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
por: Tsioufis, Panagiotis, et al.
Publicado: (2022)

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques
por: Li, Yuxin, et al.
Publicado: (2016)

Automatic Coronary Wall and Atherosclerotic Plaque Segmentation from 3D Coronary CT Angiography
por: Ghanem, Ahmed M., et al.
Publicado: (2019)

β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques
por: Okano, Taisuke, et al.
Publicado: (2020)

Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary atherosclerotic plaque
por: Baroldi, Giorgio, et al.
Publicado: (2004)

MicroRNA expression profile of human advanced coronary atherosclerotic plaques
por: Parahuleva, Mariana S., et al.
Publicado: (2018)

Recent Trends in Artificial Intelligence-Assisted Coronary Atherosclerotic Plaque Characterization
por: Gudigar, Anjan, et al.
Publicado: (2021)

Paramagnetic Manganese in the Atherosclerotic Plaque of Carotid Arteries
por: Chelyshev, Yury, et al.
Publicado: (2016)

Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability
por: Zhao, Huiying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2pqme18o5a7dptfh27phobci0b